sing Micronutrients in Smoking Cessation Treatment: A Double-Blind Randomized Placebo-controlled trial.

Not Applicable

Completed

• Conditions: icotine addiction; Nicotine addiction; Alternative and Complementary Medicine - Other alternative and complementary medicine; Mental Health - Addiction

• Registration Number: ACTRN12615000201572
• Lead Sponsor: niversity of Canterbury

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-03-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1) 18 years old or over 2) meet a 'current smoking' criteria of smoking at least three cigarettes a day for the past year 3) no serious medical conditions that require treatment during trial period 4) are not on psychoactive medication. Participants must be medication free for at least four weeks prior to beginning the trial.

Exclusion Criteria

1) under 18 years old 2) not a 'current smoker' of three or more cigarettes a day for the past year 3) on any psychoactive medication 4) any serious medical condition

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Continuous abstinence from cigarette smoking at 12-weeks measured by self report and carbon monoxide (CO) test. Continuous abstinence is defined as: 12 weeks abstinence with no relapses (a relapse is defined as returning to a normal pattern of smoking for 3 days in a row). [End of smoking cessation phase (12-weeks)]